Cargando…

The immunomodulatory effects of endocrine therapy in breast cancer

Endocrine therapies with SERMs (selective estrogen receptor modulators) or SERDs (selective estrogen receptor downregulators) are standard therapies for patients with estrogen receptor (ER)-positive breast cancer. Multiple small molecule inhibitors targeting the PI3K-AKT-mTOR pathway or CDK4/6 have...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Huanhuan, Zhou, Jun, Chen, Hailong, Li, Jiaxin, Zhang, Chao, Jiang, Xia, Ni, Chao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792133/ https://www.ncbi.nlm.nih.gov/pubmed/33413549 http://dx.doi.org/10.1186/s13046-020-01788-4

Ejemplares similares

Mature dendritic cells enriched in immunoregulatory molecules (mregDCs): A novel population in the tumour microenvironment and immunotherapy target
por: Li, Jiaxin, et al.
Publicado: (2023)

Nanomaterials with dual immunomodulatory functions for synergistic therapy of breast cancer brain metastases
por: Zhao, Zhenhao, et al.
Publicado: (2023)

High PANX1 Expression Leads to Neutrophil Recruitment and the Formation of a High Adenosine Immunosuppressive Tumor Microenvironment in Basal-like Breast Cancer
por: Chen, Wuzhen, et al.
Publicado: (2022)

Exploration of prognosis and immunometabolism landscapes in ER+ breast cancer based on a novel lipid metabolism-related signature
por: Shen, Lesang, et al.
Publicado: (2023)

Status of adjuvant endocrine therapy for breast cancer
por: Schiavon, Gaia, et al.
Publicado: (2014)

Updates in endocrine therapy for metastatic breast cancer
por: Manohar, Poorni M., et al.
Publicado: (2022)

Antiangiogenic therapy reverses the immunosuppressive breast cancer microenvironment
por: Chen, Wuzhen, et al.
Publicado: (2021)

Novel Strategies to Improve the Endocrine Therapy of Breast Cancer
por: Castrellon, Aurelio Bartolome
Publicado: (2017)

Prolactin and endocrine therapy resistance in breast cancer: The next potential hope for breast cancer treatment
por: Li, Yuan, et al.
Publicado: (2021)

Immunopathogenesis and immunomodulatory therapy for myocarditis
por: He, Wu, et al.
Publicado: (2023)

Endocrinology and hormone therapy in breast cancer: Endocrine therapy in premenopausal women
por: Pritchard, Kathleen
Publicado: (2005)

Metastatic breast cancer: Endocrine therapy landscape reshaped
por: Salkeni, Mohamad Adham, et al.
Publicado: (2017)

Endocrine therapy combined with targeted therapy in hormone receptor-positive metastatic breast cancer
por: Bian, Li, et al.
Publicado: (2020)

Endocrine Therapy for Breast Cancer: A Model of Hormonal Manipulation
por: Johnston, Simon J., et al.
Publicado: (2018)

Neoadjuvant Endocrine Therapy in Breast Cancer Management: State of the Art
por: Lerebours, Florence, et al.
Publicado: (2021)

The Present and Future of Neoadjuvant Endocrine Therapy for Breast Cancer Treatment
por: Martí, Covadonga, et al.
Publicado: (2021)

Breast cancer: are long-term and intermittent endocrine therapies equally effective?
por: Engel, Jutta, et al.
Publicado: (2020)

Multiomics technologies for comprehensive tumor microenvironment analysis in triple-negative breast cancer under neoadjuvant chemotherapy
por: Wang, Gang, et al.
Publicado: (2023)

Integrated transcriptomics, proteomics, and functional analysis to characterize the tissue‐specific small extracellular vesicle network of breast cancer
por: Shen, Lesang, et al.
Publicado: (2023)

Effects of Endocrine Therapy on Cognitive Function in Patients with Breast Cancer: A Comprehensive Review
por: Haggstrom, Lucy R., et al.
Publicado: (2022)

Pharmacogenomics of endocrine therapy in breast cancer
por: Ingle, James N
Publicado: (2013)

Current Strategies of Endocrine Therapy in Elderly Patients with Breast Cancer
por: Lee, Suk-young, et al.
Publicado: (2018)

Neoadjuvant endocrine therapy in breast cancer: current role and future perspectives
por: Barroso-Sousa, Romualdo, et al.
Publicado: (2016)

Resistance to endocrine therapy in breast cancer: molecular mechanisms and future goals
por: Szostakowska, Małgorzata, et al.
Publicado: (2018)

Hormonoresistance in advanced breast cancer: a new revolution in endocrine therapy
por: Augereau, Paule, et al.
Publicado: (2017)

Long Noncoding RNAs Involved in the Endocrine Therapy Resistance of Breast Cancer
por: Takeiwa, Toshihiko, et al.
Publicado: (2020)

Neoadjuvant Endocrine Therapy in Breast Cancer: Current Knowledge and Future Perspectives
por: Barchiesi, Giacomo, et al.
Publicado: (2020)

In vitro breast cancer models for studying mechanisms of resistance to endocrine therapy
por: Cheng, Gary J., et al.
Publicado: (2022)

ENDOCRINE ASPECTS OF BREAST CANCER
Publicado: (1958)

Endocrine Relationships in Breast Cancer
por: Barnes, D. M.
Publicado: (1982)

Network Meta-Analysis of the Effectiveness of Neoadjuvant Endocrine Therapy for Postmenopausal, HR–Positive Breast Cancer
por: Wang, Wei, et al.
Publicado: (2016)

Bispecific antibodies targeting immunomodulatory checkpoints for cancer therapy
por: Zhang, Tiancheng, et al.
Publicado: (2023)

Effect of first-line endocrine therapy in patients with hormone-sensitive advanced breast cancer: a network meta-analysis
por: Zhang, Tingting, et al.
Publicado: (2018)

Statins and endocrine resistance in breast cancer
por: Hyder, Tara, et al.
Publicado: (2021)

A Rosetta Stone for Breast Cancer: Prognostic Value and Dynamic Regulation of Neutrophil in Tumor Microenvironment
por: Zhang, Wei, et al.
Publicado: (2020)

Effects of endocrine therapy on steroid-receptor content of breast cancer.
por: Taylor, R. E., et al.
Publicado: (1982)

An emerging generation of endocrine therapies in breast cancer: a clinical perspective
por: Patel, Rima, et al.
Publicado: (2023)

Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy
por: Medrano, Ruan F.V., et al.
Publicado: (2017)

Management of hair loss associated with endocrine therapy in patients with breast cancer: an overview
por: Karatas, Fatih, et al.
Publicado: (2016)

microRNA Regulation in Estrogen Receptor-Positive Breast Cancer and Endocrine Therapy
por: Howard, Erin W., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ibapcpfbagd48tj27560hnkf5s